sterocort 4 mg
taro pharmaceutical industries ltd - triamcinolone - tablets - triamcinolone 4 mg - triamcinolone - triamcinolone - rheumatology: - active phases of systemic vasculitis: panarteritis nodosa (in patients with concomitant positive hepatitis b serology, the duration of treatment should be restricted to two weeks), polymyalgia rheumatica (pmr), pmr with giant cell arteritis, arteritis temporalis with acute visual loss;- active phases of systemic rheumatic disease: systemic lupus erythematosus, mixed connective tissue disease;- severe progressive forms of active rheumatoid arthritis, e.g. rapidly destructive forms and/or with extra-articular manifestations;- other forms of inflammatory rheumatic arthritis, provided that the severity of symptoms requires it and non-steroidal anti-inflammatory drugs (nsaids) cannot be used:spondylarthritis (ankylosing spondylitis with involvement of peripheral joints, psoriatic arthritis, enteropathic arthropathy with high inflammatory activity);- reactive forms of arthritis;- arthritis in sarcoidosis;- severe systemic form of juvenile idiopathic arthritis (still’s disease) or with iridocyclitis refractory to topical treatment.pulmonary and respiratory tract disorders: - bronchial asthma:for the long-term treatment of severe chronic asthma (category 4) and for treatment of exacerbations in adults and children.- chronic obstructive pulmonary disease (copd):for short-term treatment (max. 14 days) of exacerbations;- upper respiratory tract disorders:for short-term treatment of severe forms of allergic rhinitis in adults after failure of all other treatment alternatives, including topical glucocorticoids.dermatology: - oral initial treatment of extensive, severe, acute skin conditions responsive to glucocorticoids, such as: allergic skin disease (e.g. acute urticaria, contact dermatitis, drug eruption), atopic eczema (acute exacerbations or extensive weeping eczema), pemphigus vulgaris.nephrology: - minimal change glomerulonephritis;- extracapillary proliferative glomerulonephritis (rapidly progressive glomerulonephritis), generally in combination with cytostatics, tapering and ending treatment in goodpasture’s syndrome; for all other forms, long-term continuation of treatment;- idiopathic retroperitoneal fibrosis.
triamcinolone hexacetonide 20mg/1ml suspension for injection ampoules
esteve pharmaceuticals ltd - triamcinolone hexacetonide - suspension for injection - 20mg/1ml
kenalog 40 suspension for injection
krka d.d. - triamcinolone (triamcinolone acetonide) - suspension for injection - 40mg/ml
kenalog 40 suspension for injection
krka d.d. - triamcinolone (triamcinolone acetonide) - suspension for injection - 40mg/ml
adcortyl intra-articular/intra-dermal injection 10mg/ml suspension for injection, 1 ml
bristol-myers squibb pharmaceuticals uc - triamcinolone acetonide - suspension for injection - 10 milligram(s)/millilitre - glucocorticoids; triamcinolone
adcortyl intra-articular/intradermal injection 10 mg/ml, suspension for injection, 5ml
bristol-myers squibb pharmaceuticals uc - triamcinolone acetonide - suspension for injection - 10 milligram(s)/millilitre - glucocorticoids; triamcinolone
shin poong triamcinolone acetonide injection 40 mgml
zyfas pharma pte ltd - triamcinolone acetonide - injection - 40 mg/ml - triamcinolone acetonide 40 mg/ml
shincort i.m. injection 40 mgml
yung shin pharmaceutical (singapore) pte ltd - triamcinolone acetonide - injection - 40 mg/ml - triamcinolone acetonide 40 mg/ml
shincort injection 10 mgml
yung shin pharmaceutical (singapore) pte ltd - triamcinolone acetonide - injection - 10 mg/ml - triamcinolone acetonide 10 mg/ml
triamcinolone acetonide 40 mgml
zyfas medical co - triamcinolone acetonide - injection - 40 mg/ml - triamcinolone acetonide 40 mg/ml